We are live on ! Find out more
SFU

Stonehage Fleming (UK) Portfolio holdings

AUM $220M
1-Year Est. Return 0.72%
This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+0.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$222M
AUM Growth
+$6.24M
Cap. Flow
+$7.63M
Cap. Flow %
3.44%
Top 10 Hldgs %
26.79%
Holding
215
New
22
Increased
26
Reduced
29
Closed
28

Top Buys

Rank Stock Value
1
INGR icon
Ingredion
INGR
+$3.94M
2
GME icon
GameStop
GME
+$3.7M
3
CRL icon
Charles River Laboratories
CRL
+$2.32M
4
VMW
VMware, Inc
VMW
+$2.22M
5
ROK icon
Rockwell Automation
ROK
+$2.2M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.08M
2
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$3.26M
3
ALTR
Altera Corp
ALTR
+$2.52M
4
AMGN icon
Amgen
AMGN
+$2.26M
5
EPC icon
Edgewell Personal Care
EPC
+$2.22M

Sector Composition

Rank Sector Weight
1 Technology 19.69%
2 Consumer Discretionary 16.23%
3 Industrials 12.23%
4 Healthcare 9.98%
5 Materials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CX icon
1
Cemex
CX
$17.1B
$17.9M 8.06%
2,113,352
-1
-0% -$9
AAPL icon
2
Apple
AAPL
$4.54T
$12.4M 5.56%
393,792
-6,200
-2% -$198K
SH icon
3
ProShares Short S&P500
SH
$907M
$5.44M 2.45%
31,887
– –
INGR icon
4
Ingredion
INGR
$6.27B
$3.92M 1.76%
+49,100
New +$3.94M
GME icon
5
GameStop
GME
$9.75B
$3.87M 1.74%
+360,000
New +$3.7M
HRB icon
6
H&R Block
HRB
$5.58B
$3.61M 1.63%
121,900
+57,700
+90% +$1.81M
GLD icon
7
SPDR Gold Trust
GLD
$131B
$3.41M 1.53%
30,321
– –
DOV icon
8
Dover
DOV
$27.6B
$3.07M 1.38%
54,239
+3,095
+6% +$184K
BMY icon
9
Bristol-Myers Squibb
BMY
$133B
$3.01M 1.36%
45,250
– –
EBAY icon
10
eBay
EBAY
$50.6B
$2.92M 1.31%
115,110
– –
SLV icon
11
iShares Silver Trust
SLV
$28B
$2.91M 1.31%
193,670
+15,055
+8% +$236K
GE icon
12
GE Aerospace
GE
$374B
$2.71M 1.22%
21,244
+146
+0.7% +$18.9K
LOW icon
13
Lowe's Companies
LOW
$117B
$2.67M 1.2%
39,845
– –
GOOG icon
14
Alphabet (Google) Class C
GOOG
$4.36T
$2.62M 1.18%
97,920
+3,782
+4% +$101K
UHS icon
15
Universal Health Services
UHS
$10.2B
$2.43M 1.09%
17,100
-2,000
-10% -$250K
FISV
16
Fiserv Inc
FISV
$28.8B
$2.31M 1.04%
55,800
– –
PPLI
17
People Inc
PPLI
$3.09B
$2.29M 1.03%
+160,588
New +$2.13M
ROK icon
18
Rockwell Automation
ROK
$53.4B
$2.28M 1.03%
+18,300
New +$2.2M
EXPE icon
19
Expedia Group
EXPE
$35.4B
$2.27M 1.02%
20,800
-2,100
-9% -$217K
CTXS
20
DELISTED
Citrix Systems Inc
CTXS
$2.25M 1.01%
40,311
– –
CTAS icon
21
Cintas
CTAS
$81.9B
$2.25M 1.01%
106,400
– –
ABBV icon
22
AbbVie
ABBV
$443B
$2.24M 1.01%
33,400
– –
RTX icon
23
RTX Corp
RTX
$290B
$2.23M 1.01%
32,010
– –
CRL icon
24
Charles River Laboratories
CRL
$11.2B
$2.2M 0.99%
+31,300
New +$2.32M
NUAN
25
DELISTED
Nuance Communications, Inc.
NUAN
$2.19M 0.99%
144,722
-6,468
-4% -$91.2K
1
2 3 4 5

Similar funds

AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
KM
KS Management New York $198M AUM 43.09% 1-Year Est. Return
TC
Taylor Cottrill New London, New Hampshire $194M AUM 1.15% 1-Year Est. Return
IA
Ibbotson Associates Chicago, Illinois $193M AUM 3.52% 1-Year Est. Return
BL
Bolton LP Greenwich, Connecticut $259M AUM 30.92% 1-Year Est. Return
QA
Quintium Advisors Knoxville, Tennessee $160M AUM 2.85% 1-Year Est. Return
THP
Telegraph Hill Partners San Francisco, California $159M AUM
SGH
Schonfeld Group Holdings Jericho, New York $158M AUM 12.17% 1-Year Est. Return

Stonehage Fleming (UK)'s Q2 2015 Portfolio in Review

As of Q2 2015, Stonehage Fleming (UK) held 215 positions worth $222M, up 2.9% from $216M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Stonehage Fleming (UK) deployed $7.63M of net new capital in Q2 2015, opening 22 new positions and adding to 26 existing holdings. Its largest new stake was Ingredion: 49,100 shares worth $3.92M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Pfizer, an estimated $4.08M trimmed.

  • Stonehage Fleming (UK)'s largest Q2 2015 buy was Ingredion: 49,100 shares worth $3.92M.
  • Stonehage Fleming (UK) added most to H&R Block in Q2 2015, an estimated $1.81M increase.
  • Stonehage Fleming (UK)'s biggest Q2 2015 reduction was Pfizer, cutting an estimated $4.08M.
  • Stonehage Fleming (UK) fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2015, selling an estimated $3.26M.
  • Stonehage Fleming (UK)'s ten largest holdings make up 27% of its $222M portfolio in Q2 2015.
  • Stonehage Fleming (UK) opened 22 new positions and closed 28 in Q2 2015.
  • Stonehage Fleming (UK)'s portfolio value rose 2.9% quarter-over-quarter to $222M.

Based on Stonehage Fleming (UK)'s 13F filing for Q2 2015, filed 11 Oct 2019.